147 related articles for article (PubMed ID: 1610685)
21. Gamma/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to "T-cell-receptor-silent" aggressive lymphoma: Description of one case.
Tomasini D; Croci GA; Hotz A; Cione S; Cecchetti C; Ciambelli F; Crivelli F
J Cutan Pathol; 2021 Sep; 48(9):1197-1203. PubMed ID: 34002416
[TBL] [Abstract][Full Text] [Related]
22. Localized cutaneous small to medium-sized pleomorphic T-cell lymphoma: a report of 3 cases stable for years.
von den Driesch P; Coors EA
J Am Acad Dermatol; 2002 Apr; 46(4):531-5. PubMed ID: 11907502
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.
Alberti-Violetti S; Torres-Cabala CA; Talpur R; Corti L; Fanoni D; Venegoni L; Berti E; Duvic M
J Cutan Pathol; 2016 Dec; 43(12):1121-1130. PubMed ID: 27550169
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous lymphomas other than mycosis fungoides.
Joly P; Thomine E; Lauret P
Semin Dermatol; 1994 Sep; 13(3):172-9. PubMed ID: 7986685
[No Abstract] [Full Text] [Related]
25. Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas.
Friedmann D; Wechsler J; Delfau MH; Estève E; Farcet JP; de Muret A; Parneix-Spake A; Vaillant L; Revuz J; Bagot M
Arch Dermatol; 1995 Sep; 131(9):1009-15. PubMed ID: 7661602
[TBL] [Abstract][Full Text] [Related]
26. T-cell lymphoma: morphology, immunophenotype and clinical features.
Krajewski AS; Myskow MW; Cachia PG; Salter DM; Sheehan T; Dewar AE
Histopathology; 1988 Jul; 13(1):19-41. PubMed ID: 3061921
[TBL] [Abstract][Full Text] [Related]
27. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
30. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations.
Cocks M; Porcu P; Wick MR; Gru AA
Surg Pathol Clin; 2019 Sep; 12(3):783-803. PubMed ID: 31352988
[TBL] [Abstract][Full Text] [Related]
32. Unusual cutaneous lymphomas.
Perniciaro C
Dermatol Surg; 1996 Mar; 22(3):288-92. PubMed ID: 8599741
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
34. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
35. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
36. Clinical Practice Guidelines for Cutaneous Lymphomas.
Sutton AM; Hurley MY
Mo Med; 2015; 112(4):292-5. PubMed ID: 26455060
[TBL] [Abstract][Full Text] [Related]
37. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
38. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
39. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
40. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
